TABLE 1.

Clinical characteristics of 110 pancreatic cancer patients in tissue microarray

Variable	Value	p‐value (CTCF+ TAM high vs. low)
Age	62.8 ± 9.5	.0024
Sex (male)	64 (58.2%)	.132
WBC	5.55 (4.53, 6.7)	.164
Hb	131 (119, 137)	.425
PLT	183 (138, 239)	.237
Tbil (Total bilirubin)	19.9 (13.4, 106.6)	.014
Dbil (Direct bilirubin)	3.4 (1.95, 59.7)	.028
Fasting glucose	6.14 (5.38, 8.03)	.184
CA125	18.55 (11.4, 32.28)	.005
CA199	149.9 (49.6, 350.05)	.0042
CEA	3.64 (2.28, 7.75)	.0073
Tumour location
Head	72 (65.5%)	.326
Body/tail	38 (34.5%)	.373
Surgery
PD	72 (65.5%)	.733
DP	38 (34.5%)	.568
T stage
T1	11 (10%)	.004
T2	62 (56.4%)	.007
T3	18 (16.4%)	.003
T4	18 (16.4%)	.009
N stage
N0	50 (45.5%)	.005
N1/N2	60 (54.5%)	.017
M stage
M0	103 (93.6%)	.026
M1	7 (6.4%)	.034
American Joint Committee on Cancer (AJCC) stage
I	31 (28.2%)	.036
II	50 (45.5%)	.042
III	22 (20%)	.021
IV	7 (6.4%)	.026
Grade
Low	87 (79.1%)	.017
Median/high	23 (20.9%)	.029